Methods for assessment of cognitive failure and delirium in palliative care patients: implications for practice and research

被引:42
作者
Hjermstad, MJ
Loge, JH
Kaasa, S
机构
[1] Univ Oslo, Dept Behav Sci Med, N-0317 Oslo, Norway
[2] Norwegian Canc Soc, Oslo, Norway
[3] Norwegian Univ Sci & Technol, Fac Med, Dept Clin & Mol Med, N-7034 Trondheim, Norway
[4] St Olavs Hosp, Dept Oncol, Palliat Med Unit, Trondheim, Norway
关键词
clinical practice; cognitive failure; delirium; palliative care;
D O I
10.1191/0269216304pm920oa
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The most commonly encountered clinical conditions presenting with cognitive failure (CF) are delirium, dementia and amnestic disorders. Of these, delirium is probably the most prevalent in palliative care, and it is potentially reversible. Thus, improvement in diagnostics seems warranted. The objectives of this review were to examine the methods for assessment of CF and delirium in palliative care. Twenty-two studies were reviewed: 64% were published in 2000 or later. Twelve reports focused on delirium, six on CF, while the remaining four assessed confusion (2), hallucinations and general psychological morbidity. Median sample size was 100 (20-393). Ten different instruments were used: The Mini Mental State Exam was used in 13 studies. Five studies were validation reports of new or existing instruments. The term CF is an imprecise description of a loss in one or more of the cognitive functions. The interchangeable use of CF as a description of specific diagnoses should be avoided, as this contributes to prevalence rates that are not representative. Assessment tools that discriminate between the different diagnostic entities presenting with CF should be used in future studies.
引用
收藏
页码:494 / 506
页数:13
相关论文
共 69 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
Albert M S, 1992, J Geriatr Psychiatry Neurol, V5, P14
[3]  
American Psychiatric Association, 2000, Text revision (DSM-IV-TR), V4th, DOI [10.1176/dsm10.1176/appi.books.9780890420249.dsm-iv-tr, DOI 10.1176/DSM10.1176/APPI.BOOKS.9780890420249.DSM-IV-TR]
[4]  
American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT, P5
[5]  
[Anonymous], 1993, MENT DIS GLOSS GUID
[6]   SCREENING FOR DELIRIUM ON A GENERAL MEDICAL WARD - THE TACHISTOSCOPE AND A GLOBAL ACCESSIBILITY RATING [J].
ANTHONY, JC ;
LERESCHE, LA ;
VONKORFF, MR ;
NIAZ, U ;
FOLSTEIN, MF .
GENERAL HOSPITAL PSYCHIATRY, 1985, 7 (01) :36-42
[7]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[8]   The Memorial Delirium Assessment Scale [J].
Breitbart, W ;
Rosenfeld, B ;
Roth, A ;
Smith, MJ ;
Cohen, K ;
Passik, S .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 13 (03) :128-137
[9]   NEUROPSYCHIATRIC SYNDROMES AND PSYCHOLOGICAL SYMPTOMS IN PATIENTS WITH ADVANCED CANCER [J].
BREITBART, W ;
BRUERA, E ;
CHOCHINOV, H ;
LYNCH, M .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (02) :131-141
[10]   Delirium in the terminally ill [J].
Breitbart, W ;
Strout, D .
CLINICS IN GERIATRIC MEDICINE, 2000, 16 (02) :357-+